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Requirement for p38a in Erythropoietin Expression:
A Role for Stress Kinases in Erythropoiesis
(Kato et al., 1996; Shiozaki and Russell, 1996; Degols
and Russell, 1997). In addition to stress signaling, Spc1/
Sty1/Phh1 is also involved in development (Kato et al.,
Kumiko Tamura,* Tatsuhiko Sudo,*³ Uwe Senftleben,*
Agnes M. Dadak,² Randall Johnson,²
and Michael Karin*k
1996). The mammalian p38 SAPKs, which include p38a,*Laboratory of Gene Regulation
p38b, p38g, and p38d, are similarly regulated (Waskie-and Signal Transduction
wicz and Cooper, 1995). In addition to stress stimuli,Department of Pharmacology and
which include osmotic shock (Han et al., 1994) and²Department of Biology
hypoxia (Conrad et al., 1999), the p38 MAPKs are re-University of California, San Diego
sponsive to proinflammatory stimuli and hematopoieticLa Jolla, California 92093
growth factors (Lee et al., 1994; Crawley et al., 1997;³Biodesign Group
Foltz et al., 1997; Nagata et al., 1997). The availability
The Institute of Physical and of highly specific p38 inhibitors (Lee et al., 1994) led to
Chemical Research (RIKEN) identification of a role for p38 SAPKs in regulation of
Saitama 351-0198 inflammatory gene expression (Lee and Young, 1996;
Japan Dean et al., 1999). In addition, it was suggested that
p38 SAPKs may be involved in induction of myoblast
differentiation (Zetser et al., 1999; Puri et al., 2000; Wu
Summary et al., 2000). However, until now genetic analysis of p38
function in mammals has not been conducted. In partic-
Activity of the p38a MAP kinase is stimulated by vari- ular, the role of p38 MAPKs in normal development and
physiology has been little explored.ous stresses and hematopoietic growth factors. A role
We have used a gene targeting approach to explorefor p38a in mouse development and physiology was
the function of the p38a isozyme. Here we describeinvestigated by targeted disruption of the p38a locus.
the analysis of p38a-deficient mice that revealed anWhereas some p38a2/2 embryos die between embry-
unexpected function for p38a in mammalian develop-onic days 11.5 and 12.5, those that develop past this
ment and physiology. Whereas some p38a2/2 mousestage have normal morphology but are anemic owing
embryos die between embryonic days (E) 11.5 and 12.5,to failed definitive erythropoiesis, caused by dimin-
probably due to a placental defect (Adams et al., 2000),ished erythropoietin (Epo) gene expression. As p38a-
those that survive beyond this point are morphologicallydeficient hematopoietic stem cells reconstitute le-
normal but are anemic and display defective definitivethally irradiated hosts, p38a function is not required
erythropoiesis. This erythropoietic defect is caused bydownstream of Epo receptor. Inhibition of p38 activity
a dramatic decrease in erythropoietin (Epo) gene ex-
also interferes with stabilization of Epo mRNA in hu- pression. As p38a2/2 hematopoietic stem cells (HSC)
man hepatoma cells undergoing hypoxic stress. The can fully reconstitute hematopoiesis in lethally irradiated
p38a MAP kinase plays a critical role linking develop- hosts, p38a does not have an essential function in medi-
mental and stress-induced erythropoiesis through ating downstream responses to Epo or other hematopoi-
regulation of Epo expression. etic growth factors. A general role for p38 in regulation
of Epo gene expression is suggested by inhibition of
Introduction Epo mRNA accumulation in hypoxic human hepatoma
cells upon treatment with a specific p38 inhibitor. In
Exposure to environmental stress and strong deviations this system, p38 acts posttranscriptionally, most likely
from normal conditions, including elevated temperature, through stabilization of Epo mRNA. These results
increased or decreased osmolarity, nutrient deficiency, strongly suggest that p38a is an important regulator of
and decreased oxygen tension, results in activation of stress erythropoiesis in addition to its role in definitive
specialized signal transduction pathways and gene ex- erythropoiesis during fetal development.
pression programs that allow the organism to adapt,
survive, and maintain homeostasis. Stress-activated Results
signaling pathways may also be involved in develop-
ment. An important role in adaptation, homeostasis, and Disruption of the Murine p38a Locus
specialized stress responses is played by the stress- To disrupt the mouse p38a locus, the targeting vector
activated protein kinases (SAPKs). This evolutionary illustrated in Figure 1A was constructed. Homologous
conserved subfamily of mitogen-activated protein (MAP) integration of this vector into the p38a locus inserts a
kinases (MAPKs) includes the Jun kinases (JNKs) and neomycine resistance (neo) gene into the p38a open
the p38s (Lee and Young, 1996; Su and Karin, 1996; Ip reading frame at codon 97. As the neo cassette contains
and Davis, 1998; New and Han, 1998). In budding yeast, termination codons in all three reading frames, it is ex-
the p38 homolog Hog1 mediates the adaptive response pected to prevent translation of a p38a fusion protein.
to increased osmolarity (Brewster et al., 1993). A similar In addition, the N-terminal 97 amino acids of p38a are
function as well as responses to other stressors are not sufficient for kinase activity. Whereas mice that were
mediated by the fission yeast homolog Spc1/Sty1/Phh1 heterozygotes for the targeted p38a mutation (p38a1/2)
were alive and fertile, no live p38a homozygote null mice
were found among progeny of p38a1/2 intercrosses (Fig-kTo whom correspondence should be addressed (e-mail: karin
office@ucsd.edu). ure 1B; Table 1). However, analysis of timed pregnancies
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Figure 1. Targeted Disruption of the p38a
Locus
(A) Schematic structures of p38a cDNA, p38a
genomic clone, the targeting vector, and the
targeted allele. TGY-activating phosphoac-
ceptor sites. The black box within p38a cDNA
corresponds to the two exons shown by black
bars in the genomic clone of the p38a locus.
The neomycine resistance positive selection
marker (neo) was inserted within the EcoRI
site in the second exon corresponding to co-
don 97 of the p38a open reading frame. The
vector also includes a diphtheria toxin nega-
tive selection marker (DTA). Location of hy-
bridization probe and PCR primers (A, B, and
C) used for genotyping are indicated. Diges-
tion of genomic DNA with HindIII should gen-
erate 8 kb and 5 kb fragments from wt and
mutant alleles, respectively. Restriction sites
are also indicated: H, HindIII; S, SacI; E,
EcoRI; Sm, SmaI; B, BamHI.
(B) PCR analysis of genomic DNA obtained
from live progeny of p38a1/2 intercrosses.
(C) Southern blot analysis of HindIII-digested
genomic DNA isolated from E9.5 embryos
and tails of adult mice generated by p38a1/2
intercrosses.
revealed that until E10.5 p38a2/2 embryos are present genotypes of the different MEF cultures were deter-
mined by Southern blotting, and p38a expression wasat a frequency consistent with Mendelian inheritance
(Table 1; Figure 1C). examined by immunoblot analysis. No expression of full-
length or truncated p38a polypeptides reactive with anTo biochemically determine whether disruption of the
p38a locus abolished p38a expression or activity, mu- antiserum raised against a C-terminal p38a peptide
could be detected in p38a2/2 MEFs (Figure 2A). Similarrine embryonic fibroblasts (MEFs) were derived from
E10.5 to E11.5 progeny of p38a1/2 intercrosses. The results were obtained using two different antibodies
raised against full-length p38a or an N-terminal peptide
(data not shown). In addition, the level of p38a expres-
sion in p38a1/2 MEFs was reduced in comparison toTable 1. Genotypes of Offspring from p38a1/2 Intercrosses
p38a1/1 MEFs. No compensatory change in expression
Genotype
Phenotype of the closely related p38b isozyme could be detected.
Immunecomplex kinase assays revealed complete ab-Total Livea Dead
Stage (Litters) 1/1 1/2 2/2 2/2 2/2 sence of p38a kinase activity in UV-irradiated p38a2/2
MEFs (Figure 2B). Thus, the mutant p38a allele gener-Postnatal 44 (6) 13 31 0
ated by our targeting vector is a null allele.E19.5 11 (2) 4 7 0
E18.5 9 (2) 4 5 0
E16.5 31 (4) 10 15 6 6
E15.5 37 (5) 13 21 3 3 p38a2/2 Embryos Die in Midgestation
E14.5 40 (5) 14 20 6 6 and Are Anemic
E14.0 8 (1) 3 4 1 1 To identify at which developmental stage p38a-deficient
E13.5 52 (7) 19 29 4 3 1 embryos die, the phenotypes and genotypes of offspring
E12.5 91 (10) 21 53 17 11 6 from p38a1/2 intercrosses were examined between E8.5
E11.5 92 (11) 33 44 15 10 5
and E19.5. Live p38a2/2 embryos were detected up toE10.5 169 (16) 42 87 40 40 0
E16.5, but after E11.5 their frequency was considerablyE9.5 81 (11) 23 36 22 22 0
lower than what was expected based on Mendelian in-E8.5 79 (10) 20 40 19 19 0
heritance (Table 1). We did notice, however, that the
a Surviving embryos were defined as those with beating hearts at actual time at which the p38a2/2 mice died varied from
time of dissection.
one animal facility to another: while animals housed in
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initiated in the yolk sac, followed by the aorta-gonad-
mesonephros (AGM) region. After establishment of
blood circulation at E8.0, multipotent cells can be found
in the blood vessels and these cells colonize the liver,
spleen, thymus, and omentum (Godin et al., 1999). At
midgestation, the FL becomes the major hematopoietic
organ with hematopoietic activity starting around E11.0
to E12.5 until 1 week postnatally. Visual and histological
examination revealed that p38a2/2 yolk sac blood ves-
sels and the vasculature of the embryo proper appeared
normal using PECAM antibody (data not shown). How-
ever, histological examination of wt and p38a2/2 FLs
revealed a marked decrease in the number of circulating
hemoglobinized red blood cells and erythropoietic foci
in E11.5 to E13.5 p38a2/2 embryos (Figures 3C and 3D).
While blood vessels of wt embryos contained both enu-
cleated and nucleated erythrocytes, the small number
of erythrocytes found in the blood vessels of p38a2/2
embryos were mostly nucleated and very few enucle-
ated red blood cells were detected (Figure 3D). The total
number of nucleated cells in E11.0 p38a2/2 FLs was
4-fold lower than in wt counterparts. Cytospin analysis
of wt FL cells revealed cells in all stages of erythropoie-
sis, whereas similar preparations of p38a-deficient FLs
contained mostly hepatocytes with few proerythroblasts
and an even lower number of more mature erythroid
cells (Figure 3E).
Figure 2. Analysis of p38a Expression and Function in WT and Mu- Defective Erythropoiesis in p38a2/2 Embryos
tant Embryonic Fibroblasts We examined FL hematopoiesis in E11.5 wt and p38a2/2
(A) MEF cultures were established from E10.5±E11.5 embryos of the embryos by flow cytometry using markers that are char-
indicated genotypes. Expression of p38a and p38b was examined acteristic of different hematopoietic cell types and de-
by immunoblotting with specific antibodies. velopmental stages, including CD34 (detecting hemato-
(B) p38a was immunoprecipitated from nonstimulated or UV-irradi-
poietic progenitors), CD44 (detecting hematopoieticated wt and p38a-null MEFs. Kinase activity was measured using
cells), c-kit (hematopoietic stem cells), and Ter-119 (ery-a GST-ATF2 fusion protein as a substrate. Protein levels were nor-
throid cells) (Ikuta et al., 1990; Kansas et al., 1990; Neu-malized by coomassie blue staining.
bauer et al., 1998; Ghaffari et al., 1999). Analysis of sin-
gle-cell suspensions with the CD34 and CD44 markers
revealed a modest but significant increase in the relativeSan Diego did not generate p38a2/2 embryos that sur-
vived beyond E13.5, those that were kept in Saitama, fraction of CD34lowCD44high cells in p38a2/2 FLs, whereas
the frequency of CD34negCD44low cells had decreasedJapan generated p38a2/2 embryos that developed to
E16. The basis for this difference is not clear, but we (Figure 4). A similar but more dramatic change in CD44
expression occurs in EpoR2/2 and Jak22/2 FLs (Neu-found that the frequency of live p38a2/2 that develop
beyond E11.5 had dramatically decreased upon back- bauer et al., 1998). Although CD44 is expressed by all
types of mature blood cells, its expression level changescrossing the p38a1/2 heterozygotes [which were of (129/
Sv 3 129/J) F1 3 C57BL/6J background] into the C57BL/ with cell differentiation, and CD34lowCD44high cells repre-
sent hematopoietic progenitors (Ghaffari et al., 1999).6J background. Further examination suggested the ex-
istence of two distinct defects caused by the p38a defi- Moreover, expression of CD44 is downregulated during
erythroid cell differentiation and maturation (Kansas etciency. Whereas a certain proportion p38a2/2 mice die
between E11.5 and E12.5 and some of them appear al., 1990). FLs of p38a2/2 embryos also exhibited a mod-
est increase in the relative abundance of CD34lowc-kitposgrowth retarded, those that survive beyond that point
were morphologically similar to their wild-type (wt) coun- cells (Figure 4). Expression of c-kit marks HSCs capable
of long term reconstitution (Ikuta and Weissman, 1992).terparts except for a slight pallor. In those embryos
that died at E11.5, histological examination revealed a On the other hand, expression of Ter-119, which marks
committed erythropoietic precursors beyond the ery-marked paucity of embryo-derived blood vessels in the
labyrinth layer of the placenta (H. Yoshida and K. T., throid colony-forming unit (CFU-E) stage (Ikuta et al.,
1990; Neubauer et al., 1998), was reduced in p38a2/2unpublished data). The work described below was
based on the analysis of only those p38a2/2 embryos FLs. The p38a2/2 FLs contained a higher relative level of
Ter-119negCD44high hematopoietic progenitors and Ter-that were morphologically normal and alive at E11.5 or
later time points. The fetal livers (FLs) of the live p38a2/2 119posCD44neg primitive erythroid cells and a lower level
of more mature Ter-119posc-kitneg cells. These resultsembryos were smaller than those of wt counterparts
and their major blood vessels lacked color (Figure 3A). strongly suggest that the absence of p38a results in a
severe block to erythroid differentiation.In addition, the yolk sacs that surrounded these embryos
were of normal size but contained few circulating red Further evidence for a defect in definitive erythropoie-
sis in p38a2/2 embryos was provided by reverse tran-blood cells (Figure 3B).
During normal murine development, hematopoiesis is scription (RT)±polymerase chain reaction (PCR) analysis
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Figure 3. Morphological Phenotype of
p38a2/2 Embryos
(A) Appearance of p38a1/1 and p38a2/2 E12.5
mouse embryos. Note the smaller liver, ab-
sence of color in major blood vessels, and
general pallor of the p38a2/2 embryo.
(B) E16.5 p38a1/1 and p38a2/2 mouse em-
bryos within their yolk sacs. Note the reduced
amount of blood in the p38a2/2 embryo and
yolk sac.
(C) Sections of FLs from p38a2/2 and p38a1/1
E11.5 embryos were stained with hematoxilin
and eosin (H&E). The p38a1/1 FL contains
numerous dark staining erythropoietic ele-
ments, while p38a2/2 FL contains primarily
hepatocytes and only a small number of prim-
itive nucleated erythrocytes.
(D) Sections through blood vessels in FLs of
p38a2/2 and p38a1/1 E13.5 embryos stained
with H&E. Note the almost complete absence
of enucleated erythrocytes in the p38a2/2
sample.
(E) Liver cytospin preparations from E12.5
p38a1/1 and p38a2/2 embryos. Giemsa stain-
ing reveals numerous erythropoietic cells in
all stages of differentiation, including pro-
erythroblasts (E), basophilic erythroblasts (B),
polychromatic erythroblasts (P), orthochro-
matic erythroblasts (O), and enucleated
erythrocytes (N), within cells isolated from
p38a1/1 FL. In contrast, FL cytospin prepara-
tions from a p38a2/2 embryo show proeryth-
roblasts (E), but erythroid cells at later stages
of differentiation are rare.
of globin gene expression. The levels of bh1-, ey2-, and poiesis, was highly reduced in p38a2/2 embryos (Figure
5A). Collectively, these results indicate that embryonic (orz-globin transcripts, which are expressed predominantly
during embryonic (primitive) erythropoiesis (Whitelaw et primitive) erythropoiesis proceeds normally in p38a2/2
embryos but definitive erythropoiesis is severely defective.al., 1990), were similar in wt and knockout FLs (Figure
5A). The levels of a-globin transcripts, which are pro- To better define the block in definitive erythropoiesis,
we measured the ability of cells derived from wt andduced during both embryonic and definitive erythropoie-
sis, were also not substantially different between wt and p38a2/2 E10.5 FLs to form CFU-Es and the more imma-
ture erythroid burst-forming units (BFU-E). These colonyp38a2/2 FLs. However, expression of bmaj-globin tran-
scripts, which first occurs in FLs during definitive erythro- types reflect the presence of committed erythroid pro-
Essential Role for p38a in Erythropoiesis
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Figure 4. Flow Cytometry of FL Hematopoietic Cells from E11.5 WT and Mutant Embryos
Expression of different cell surface markers is depicted. Cell suspensions from E11.5 FLs were labeled with anti-c-kit, which marks hematopoietic
stem cells, anti-CD44, which marks all hematopoietic cells, anti-Ter-119 to identify differentiated erythroid cells, or anti-CD34 to mark
hematopoietic progenitors. A minimum of 5 3 105 live cells were analyzed for each FL.
genitors (Gregory and Eaves, 1978). While the total num- When normalized to the levels of GAPDH mRNA, the
relative amount of Epo mRNA in p38a2/2 FLs was nearlyber of CFU-E and BFU-E in p38a2/2 FLs was consider-
ably lower than in those of wt littermates, upon normal- ten times lower than in wt, whereas the relative amount
of SCF mRNA was 2-fold lower in p38a2/2 FLs than inization to the total number of nucleated cells per FL,
no decrease in the frequency of BFU-Es and CFU-Es wt FLs (Figure 6C). We also observed a small decrease
in Thrombopoietin (Tpo) mRNA levels in p38a2/2 FLs,between mutant and wt was detected. Most important,
p38a2/2 erythroid progenitors were capable of complete as measured by real-time PCR (data not shown). We
also examined expression of mRNAs coding for GM-terminal differentiation in vitro, as indicated by benzidine
staining. Collectively, the phenotype of p38a2/2 em- CSF, IL-3, IL-6, IL-9, and IL-13, but their levels were too
low to be detected in E11.5 FL (K. T., unpublished data).bryos is comparable to that of Epo2/2 embryos (Wu et
al., 1995), suggesting that the major defect in p38a- The Epo gene is expressed primarily in FL and adult
kidney and is regulated in response to oxygen availabil-deficient embryos is in the expansion and differentiation
of CFU-E progenitors to more mature erythroid cells. ity (Ebert and Bunn, 1999). Unfortunately, there is a lim-
ited number of tissue culture models for studying the
regulation of Epo gene expression. Most useful for suchp38a Is Required for Optimal Epo Expression
studies are the human hepatoma cell lines Hep3B andIn addition to stress stimuli, p38 catalytic activity is stim-
HepG2 (Ebert and Bunn, 1999). Due to their dedifferenti-ulated by several hematopoietic growth factors, includ-
ated nature, hepatoma cell lines may resemble FL cells,ing Epo, stem cell factor (SCF), and IL-3 (Crawley et al.,
which are the major site of Epo synthesis during devel-1997; Foltz et al., 1997; Nagata et al., 1997). Although
opment (Ebert and Bunn, 1999). To examine the generalsuch findings suggest that p38a may act downstream
involvement of p38 MAPKs in the regulation of Epoto Epo receptor (EpoR), the hematopoietic defect of
gene expression, we used the specific p38 inhibitorp38a2/2 embryos described above was more similar to
SB203580, which mostly affects the p38a and p38b iso-that of Epo2/2 embryos than embryos lacking EpoR or
zymes (Lee and Young, 1996). Treatment with SB203580a downstream component of its signaling pathway (Wu
inhibited the accumulation of Epo mRNA in Hep3B cellset al., 1995; Neubauer et al., 1998; Parganas et al., 1998).
incubated with the hypoxiamimetic inducer CoCl2 (Fig-Furthermore, p38a2/2 erythropoietic progenitors un-
ure 6D). To determine at which level p38 regulates Epodergo terminal differentiation in vitro in the presence of
gene expression, we examined the effect of SB203580exogenous Epo. We therefore explored the possibility
on induction of Epo transcription using a run-on assay.that p38a may be required for optimal expression of
Despite its major effect on Epo mRNA accumulation,Epo and other hematopoietic growth factors. RNA was
treatment with SB203580 had only a marginal effect onextracted from FLs of morphologically normal and viable
the rate of Epo gene transcription in the absence orE11±E11.5 wt and p38a2/2 fetuses. The relative amount
presence of CoCl2 (Figure 6E). We attempted to measureof Epo transcripts was first examined by RT±PCR analy-
the effect of the p38 inhibitor on Epo mRNA turnover,sis. To ensure linearity, we examined the relative abun-
but as previously described (Goldberg et al., 1991), wedance of Epo cDNA as different cycles. The results indi-
found that inhibition of transcription with actinomycincated a dramatic reduction in the level of Epo mRNA
D resulted in Epo mRNA stabilization (data not shown).expression in p38a2/2 FLs (Figure 6A). By comparison,
As the only other way to prevent new Epo gene transcrip-only a modest decrease in expression of SCF mRNA was
tion entailed the removal of the inducer, CoCl2, whichdetected in p38a2/2 FLs (Figure 6B). To more accurately
also causes Epo mRNA stabilization (Goldberg et al.,determine the differences in Epo and SCF mRNA levels
1991), we resorted to a different approach. Cells werebetween wt and p38a2/2 FLs, we analyzed samples of
FL RNA by quantitative real-time PCR (Heid et al., 1996). treated with CoCl2 for 15 hr to induce accumulation of
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active in FL cells of E11.5 fetuses, but consistent with
the reconstitution results shown below, its activity is not
stimulated by Epo. (Figure 6H).
p38a2/2 Hematopoietic Stem Cells Reconstitute
Lethally Irradiated Hosts
The results described above suggest that the major ab-
erration in p38a2/2 embryos that leads to the defect in
definitive erythropoiesis is Epo deficiency. Furthermore,
in FL Epo itself does not seem to be involved in regula-
tion of p38 activity. Yet, other experiments suggested
that p38 activity is stimulated by a variety of hematopoi-
etic growth factors, including Epo and SCF (Crawley et
al., 1997; Foltz et al., 1997; Nagata et al., 1997). To
rigorously examine the possibility that p38a function
may also be required downstream to EpoR or other
hematopoietic growth factor receptors, we tested the
ability of p38a2/2 FL HSC to reconstitute hematopoiesis
in lethally irradiated hosts.
Adult B6.SJL mice, which express the CD45.1 antigen,
were lethally irradiated and injected with single-cell sus-
pensions of E11.5 wt and p38a2/2 FLs, which express
the CD45.2 antigen. While mock-injected lethally irradi-
ated mice did not survive beyond 2 weeks (data not
shown), mice reconstituted with either wt or p38a2/2
FL cells survived for at least 20 weeks. At 14 weeks
postreconstitution, peripheral blood was analyzed for
cell surface markers characteristic of donor-derived ery-
throid, myeloid, and lymphoid cells. The reconstitution
capacity of p38a2/2 FL cells was very similar to that of wt
cells (Figure 7). In both cases, complete reconstitution of
erythroid, myeloid (granulocytes and monocytes), and
lymphoid (B and T) cells was observed. Thus, the hema-
topoietic deficiency of p38a2/2 mice is not cell autono-
mous and can be corrected by host derived factor(s).
Discussion
Like other stress-activated protein kinases, members of
the p38 group of MAPKs are rapidly activated in re-
sponse to a wide variety of stress stimuli, including heatFigure 5. A Defect in Definitive Erythropoiesis in p38a2/2 Embryos
shock, osmotic shock, UV irradiation, and proinflamma-(A) Expression of globin genes in E11 FL of wt and p38a2/2 (KO)
tory cytokines (Lee and Young, 1996; Su and Karin, 1996;embryos. Samples were amplified for 20, 23, or 26 cycles, using
gene specific primers. GAPDH mRNA levels were measured as a Ip and Davis, 1998). It was therefore expected that the
control. major, if not sole, function of the p38 MAPKs is in activa-
(B) Analysis of CFU-E- and BFU-E-forming ability of FL cells from tion of stress responses and induction of proinflamma-
p38a1/1, p38a1/2, and p38a2/2 E11 embryos. Top panel, the total tory cytokines, chemokines, and other proteins involved
number of colony-forming units per FL was determined. Bottom in inflammation. The development of specific p38 inhibi-
panel, the frequency of progenitor cells per 104 nucleated FL cells.
tors that target both the p38a and p38b isozymes hasThe depicted values are averages 6 standard errors determined for
verified the important role of p38 MAPKs in activationthree embryos of each genotype.
and regulation of inflammatory and innate immune re-
sponses, at least in cultured cells (Lee and Young, 1996;
Crawley et al., 1997; Dean et al., 1999). Further evidenceEpo transcripts. At that time, the cells were left with
CoCl2 and were incubated for 3 additional hr in the ab- for the involvement of p38a in proinflammatory signaling
was recently provided by the analysis of p38a2/2 ES cellssence or presence of SB203580. Despite the small effect
on Epo gene transcription (Figure 6E), the 3 hr treatment (Allen et al., 2000). Based on such results, a considerable
current effort is being dedicated to the developmentwith SB203580 resulted in a 2-fold decrease in Epo
mRNA level (Figure 6F). Given that the half-life of Epo of p38 inhibitors as antiinflammatory drugs. Yet, the
function of p38 MAPKs in development and normalmRNA under normoxic conditions is 3 hr (Goldberg et
al., 1991), these results suggest that inhibition of p38 physiology has not been extensively explored. We and
others (Adams et al., 2000) addressed the function of theactivity results in Epo mRNA destabilization. We there-
fore conclude that p38 acts posttranscriptionally, most p38a isozyme in mouse development and physiology
through targeted disruption of the p38a locus. As de-likely by increasing the stability of Epo mRNA. As pre-
viously reported for PC12 cells (Conrad et al., 1999), scribed above and elsewhere (Adams et al., 2000), the
p38a deficiency results in two distinct developmentaltreatment of Hep3B cells with CoCl2 resulted in p38a
activation (data not shown) and this activity was sensi- defects that appear to be influenced by the genetic
background of the mice. Using 129XC57BL/6J hybrids,tive to SB203580 (Figure 6G). We also find that p38a is
Essential Role for p38a in Erythropoiesis
227
Figure 6. p38a Is Required for Epo Ex-
pression
(A) RT±PCR analysis of Epo mRNA expres-
sion in E11 FL of wt and p38a2/2 (KO) em-
bryos. Samples were amplified for 50 or 60
cycles. GAPDH mRNA levels were measured
as a control.
(B) RT±PCR analysis of SCF mRNA expres-
sion in E11 FL of wt and p38a2/2 (KO) em-
bryos. Samples were amplified for 30 cycles.
(C) Quantitation of Epo and SCF mRNA levels
by real-time PCR. The levels of Epo, SCF, and
GAPDH transcripts in RNA samples of E11.5
wt and p38a2/2 FL were determined by real-
time PCR. The concentrations of Epo and
SCF transcripts were normalized relative to
those of GAPDH transcripts. Note that the
scales for Epo and SCF are different.
(D) Hep3B cells were cultured in medium con-
taining 50 mM CoCl2 for 9 hr. The cells were
also treated with SB203580 (10 or 20 mM)
or vehicle (DMSO), as indicated. Expression
levels of human Epo mRNA were determined
by Northern blot hybridization. Actin mRNA
levels were measured as a control.
(E) p38 inhibitor does not interfere with induc-
tion of Epo gene transcription. The transcrip-
tion rates of the Epo and b-actin genes were
measured in nuclei isolated from Hep3B cells
that were untreated or treated with 50 mM of
CoCl2 for 4±8 hr. Cells were incubated or not
with 20 mM SB203580. The values represent
relative fold induction and are averages of
two experiments.
(F) p38 inhibitor destabilizes Epo mRNA.
Hep3B cells were incubated in medium con-
taining 50 mM CoCl2 for 15 hr. One dish was
left in 50 mM CoCl2, one dish incubated with
50 mM CoCl2 plus 10 mM SB203580, and the
third dish in 50 mM CoCl2 plus 20 mM
SB203580. After 3 hr, RNA was isolated and
analyzed by Northern blot hybridization using
human Epo and b-actin probes. Expression
of Epo mRNA was normalized to that of
b-actin mRNA after quantitation by phospho-
imaging.
(G) CoCl2 induced SB20350-sensitive p38a ki-
nase. Hep3B cells were incubated with 50 mM
of CoCl2 or exposed to UV-C radiation (40 Jxm22). After 8 hr lysates were prepared and p38a kinase activity was determined by immunecomplex
kinase assays in the presence (plus signs) or absence (minus signs) of 10 mM SB203580.
(H) Detection of activated p38a in fetal liver. MEFs from wt and p38a2/2 fetuses were exposed or not to UV-C radiation a potent p38 MAPK
activator. Single-cell suspensions of FLs from E11.5 wt fetuses were incubated with or without 30 U/ml murine Epo for 5±10 min at 378 C.
Cell lysates were separated by SDS±PAGE, transferred to Immobilon membrane, and immunoblotted with an antibody that specifically
recognizes the activated form of p38 (phospho-p38). The migration position of phospho-p38a is indicated.
we find that some of the p38a2/2 embryos die between of Epo mRNA, but the characteristics of their hematopoi-
etic defect are almost identical to those of Epo2/2 miceE11.5 and E12.5, while a considerable proportion of the
p38a-deficient embryos develop beyond this point and (Wu et al., 1995). In both cases, the homozygous null mice
die during midgestation and prior to their death exhibitsurvive up to E16.5 with normal morphology but highly
anemic appearance. Whereas Adams et al. (2000) have severe anemia, decreased FL cellularity, and impaired de-
finitive erythropoiesis. However, unlike mouse bryos thatfocused their studies on the basis for the earlier lethality,
which is the predominant phenotype after backcrossing are deficient in essential downstream components of the
EpoR signaling pathway, for instance Jak22/2 embryosto the C57BL/6 background, and suggest that it is due
to a requirement for p38a in placental development, (Neubauer et al., 1998; Parganas et al., 1998), the FLs
of p38a2/2 and Epo2/2 (Wu et al., 1995) embryos containwe have investigated the basis for the anemia that is
observed in those p38a-deficient embryos that do not BFU-Es and CFU-Es that are formed with normal fre-
quency and can reconstitute erythropoiesis in lethallydie due to placental insufficiency. The basis for the ane-
mic phenotype has been traced to a deficiency in Epo irradiated hosts or undergo terminal differentiation in
vitro in the presence of exogenous Epo. It is thereforegene expression.
Not only do those p38a2/2 embryos that survive be- clear that despite the ability of several hematopoietic
growth factors, including Epo itself, to activate p38yond E12.5 exhibit a dramatic reduction in accumulation
Cell
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Figure 7. Reconstitution of Hematopoiesis by Adoptive Transfer of WT and p38a2/2 FL Cells
Peripheral blood cells were withdrawn 14 weeks after adoptive transfer of FL cells from wt or p38a2/2 E11.5 embryos into lethally irradiated
hosts. Cell surface expression of different lineage markers is shown. The dot plots represent the log of fluorescence intensities of cells falling
into the CD45.2 gate. Monoclonal antibodies used were against Ter-119 (erythroid cells), HSA (heat stable antigen, lymphoid precursors), Gr-1
(granulocytes), F4/80 (monocytes), CD4 and CD8 (T lymphocytes), B220 (B lymphocytes), and CD43 (leukocytes). The percentages of cell
populations in the different quadrants are indicated.
MAPKs in cultured cells (Crawley et al., 1997; Foltz et it appears that HIF-1 is not a direct target for SB203580-
sensitive p38 MAPKs, and the induction of HIF-1a phos-al., 1997; Nagata et al., 1997), at the least the p38a
phorylation in p38a2/2 MEFs is unaltered (A. M. D. andisozyme is not required for expansion and differentiation
R. J., unpublished data; Richard et al., 1999). Just likeof hematopoietic progenitors in response to these fac-
the JNKs, the p38 MAPKs were first found to phosphory-tors. The most likely molecular defect in the anemic
late and regulate the activity of transcription factors, butp38a2/2 embryos that accounts for their hematopoietic
recent results indicate that both JNKs (Chen et al., 1998)deficiency is the inability to accumulate sufficient
and p38 MAPKs (Dean et al., 1999; Winzen et al., 1999)amounts of Epo mRNA. Formally, however, it is also
are also involved in the regulation of mRNA turnover.possible that p38a may not be directly involved in the
Due to the absence of appropriate culture models, theregulation of Epo mRNA metabolism and instead is re-
developmental cues that regulate Epo gene expressionquired for formation or maintenance of the cells respon-
during embryonic development remain unknown (Ebertsible for Epo production. Although it is essentially im-
and Bunn, 1999). Also, because of the rather early em-possible to rule out this possibility, as the only marker
bryonic lethality of Hif1a2/2 embryos (Iyer et al., 1998;for Epo-producing cells is Epo itself, the experiments
Ryan et al., 1998), it has been impossible so far to evalu-conducted with Epo-producing human hepatoma cells
ate the role of HIF-1, the major hypoxia-induced tran-strongly suggest that p38a is directly involved in regula-
scription factor, in the developmental control of Epotion of Epo mRNA metabolism.
gene expression. Our results, however, which attributeIn addition to p38a-deficient mouse embryos, inhibi-
a critical role for p38a in regulation of Epo mRNA accu-tion of Epo mRNA accumulation was also observed in
mulation both in mouse embryos and in human hepa-human Hep3B hepatoma cells subjected to hypoxia and
toma cells subjected to hypoxia, suggest that p38a istreated with the specific p38 inhibitor SB203580. Al-
important for regulation of fetal Epo gene expression.though in adults the major site of Epo production is the
However, it remains to be examined whether p38 iskidney, hepatoma cells are similar in their differentiation
involved in the hypoxic induction of Epo mRNA in thestate to FL cells, which are the major producers of Epo
kidney during adult life. Nevertheless, given the activa-during fetal life (Ebert and Bunn, 1999). As SB203580
tion of p38a and p38g by hypoxia (Conrad et al., 1999;
targets both the p38a and p38b isozymes (Lee and K. T., unpublished data), it is reasonable to postulate
Young, 1996), it is not clear whether the observed effect that hypoxia may provide an important signal that trig-
is solely due to inhibition of p38a. Nevertheless, we gers Epo gene expression during embryogenesis. In
found that treatment of Hep3B cells with the hypoxiami- support of this hypothesis, it was observed that a hyp-
metic agent CoCl2 resulted in p38a activation (K. T., oxia-responsive reporter is activated during mouse em-
unpublished data), and previous studies have shown bryogenesis, suggesting that the embryo is subject to
that only p38a and p38g (which is insensitive to mild hypoxia during certain periods of development
SB203580) are responsive to hypoxia (Conrad et al., (Ryan et al., 1998). Furthermore, Epo serum concentra-
1999). The hypoxic induction of Epo gene expression is tions are increased in anemic or hypoxic human fetuses
mediated both at the transcriptional and posttranscrip- (Fahnenstich et al., 1996). Hence, it is likely that fetal
tional levels, the latter through mRNA stabilization (Ebert erythropoiesis may be regulated to maintain oxygen ho-
and Bunn, 1999). Our results suggest that p38a affects meostasis in the embryo, in much the same way it is
Epo gene expression at the posttranscriptional level, regulated in response to environmental cues in the adult.
most likely through mRNA stabilization. The major tran- In addition to revealing the unexpected role of p38a
scription factor responsible for the hypoxic induction of in regulation of Epo production and erythropoiesis, as
well as placental development (Adams et al., 2000), thethe Epo gene is HIF-1 (Ebert and Bunn, 1999), but so far
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RNA and Transcription Rate Analysisphenotypes associated with p38a null mutations sug-
Total RNA was isolated from livers of wt and p38a-deficient E11±gest that the function of p38a, at least during mouse
E11.5 embryos using the Trizol purification method as recom-embryogenesis, is nonredundant. This is quite different
mended by the manufacturer. For cDNA synthesis, 1 mg of totalfrom what has been revealed by mutant mice with dis-
RNA in a final volume of 12 ml of DEPC-treated water was heated
ruptions of only one of the Jnk loci or the Erk1 locus to 708C for 5 min and chilled on ice for 2 min. One microliter of oligo
(Yang et al., 1997; Dong et al., 1998; Kuan et al., 1999; (dT) primer (500 ng/ml) was added to the reaction mix, which included
PageÁ s et al., 1999; Sabapathy et al., 1999a, 1999b). None 5 ml of 103 first-strand buffer, 1 ml of 10 mM dNTPs, and 1 ml of
of these mutants has revealed a critical role for any of MMLV-RT (50 U/ml). The reactions were incubated at 428C for 50 min.
The primers and the conditions for PCR were previously describedthe affected MAPKs in development, and therefore, it
(Weiss et al., 1994; Eferl et al., 1999). Nuclear run-on experimentshas been assumed that these protein kinases may have
were conducted as described (Greenberg, 1987) using nuclei iso-overlapping functions, at least during development, as
lated from Hep3B cells untreated or treated with 50 mM CoCl2 forrevealed by the severe developmental defect of Jnk12/2
different lengths of time. After in vitro transcription in the presence ofJnk22/2 double mutants (Sabapathy et al., 1999b).
[a-32P]UTP, radiolabeled RNA was isolated using the Trizol method.
In summary, our results identify a clear function for the Equal amounts of [32P]RNA were hybridized to nitrocellulose filters to
p38a MAPK in normal development through its ability to which single-stranded human Epo and b-actin cDNAs were spotted.
regulate the accumulation of Epo mRNA. As p38a activ- Results were quantitated using a phosphoimager.
ity is also regulated by hypoxia, the major environmental
signal that controls Epo production and erythropoiesis
Real-Time PCR
(Ebert and Bunn, 1999), p38a provides an important Quantitative real-time PCR based measurement of RNA abundance
yet previously unexpected link between stress-induced (Heid et al., 1996) was carried out using gene-specific double fluo-
erythropoiesis and developmental erythropoiesis. rescently labeled probes and the ABI PRISM 7700 Sequence Detec-
tor (PE Applied Biosystems, Norwalk, CT). 6-carboxy fluorescein
(FAM) was the 59 fluorescent reporter, and tetramethylrhodamine
Experimental Procedures (TAMRA) was added to the 39 end as a quencher. The following
primer and probe sequences were used: mGAPDH-247 forward
Generation of p38a Knockout Mice primer (F), 59-CAACGGGAAGCCCATCAC-39; mGAPDH-311 reverse
Conditions for blastocyst injection of correctly targeted and karyo- primer (R), 59-CGGCCTCACCCCATTTG-39; mGAPDH-171 probe,
typically normal ES clones and breeding to generate mice homozy- 59-TGGCACCGTCAAGGCTGAGAACG-39; mEPO-174F, 59-CAGGCC
gous for the mutated p38a gene were as described (Hu et al., 1999; CTGCTAGCCAATT-39; mEPO-251R, 59ACGTAGACCACTGATGGCTT
Sabapathy et al., 1999a). Mouse genomic DNA library was screened TGT-39; mEPO-196 probe, 59-CCAAGCCACCAGAGACCCTTCAGC
to isolate a genomic DNA clone covering the N-terminal portion of TTC-39; mSCF-6F, 59GATCTGCGGGAATCCTGTGA-39; mSCF-103R,
the p38a coding region. This clone was used to construct the tar- 59-CGGCGACATAGTTGAGGGTTA-39; mSCF-39 probe, 59-AGACAT
geting vector described in Figure 1, using standard procedures (Hu TACAAAACTGGTGGCTCTTCCAAAT-39; mTPO-254F, 59-CCTGTGA
et al., 1999). Details of the construction are available upon request. CCCCAGACTCCTAAT-39; mTPO-323R, 59-CACTGACTCAGTCGGC
The targeting vector was transfected into R1 ES cells derived from TGTGA-39; mTPO-278 probe, 59-AACTGCTGCGTGACTCCCACC
the 129 strain (Hu et al., 1999). Two independent p38a1/2 ES clones TCC-39. The specificity of PCR primers was tested under normal
were injected into blastocysts of C57BL/6J mice. Male mice with a PCR conditions before quantitation. Real-time PCR was performed
high degree of chimerism were crossed to C57BL/6J females to with 25 ng of reverse transcription products in a total volume of 50
generate p38a1/2 mice. Mouse tail DNA was prepared from z1 mm
ml in triplicates. PCR was performed at 508 C for 2 min, at 958C for
tail snips of 1- to 2-week-old progeny. Genotyping was performed 10 min and then for 45 cycles at 958 C for 15 s, and at 608 C for 1
by Southern blot analysis or by PCR analysis of tail- and embryo- min on the ABI PRISM 7700 Detection System. Standard curves
derived DNA. Multiplex PCR with three primers per reaction was were generated using serial dilutions of a plasmid containing the
used. The primers were as follows: A, 59-CCCTATACTCCCTCTCTG cDNA of interest.
TGTAACTTTTG-39; B, 59-CCCAAACCCCAGAAAGAAATGATG-39;
and C, 59-TTCTGTGACAACGTCGAGCACAGCTG-39. Using these
primers at 1 cycle at 948C for 5 min followed by 35 cycles at 948C Colony Formation Assays
Cells were prepared from livers of E11±E12 embryos in a-MEMfor 30 s, 558C for 30 s, 728C for 1 min, with an extension step of 10
min at 728C at the end of the last cycle, produced 800 bp and 450 medium (GIBCO±BRL) and counted in the presence of 3% acetic
acid to lyse erythrocytes. Cell suspensions and recombinant cyto-bp fragments from the mutant and wt alleles, respectively.
kines specific for each assay were mixed with MethoCult M3230
(StemCell Technologies) as described (Neubauer et al., 1998). Cells
Analysis of p38a Activity and Expression were plated in 35 mm dishes and cultured at 378C, 5% CO2. For the
Embryonic fibroblasts from p38a1/1, p38a1/2, and p38a2/2 embryos CFU-E assay, cells were cultured in 0.2 U/ml recombinant murine
were cultured in DMEM supplemented with 10% fetal bovine serum. (rm) erythropoietin (R&D Systems), and benzidine-positive CFU-E
Cell lysates were analyzed for expression of p38a and p38b as colonies were scored at day 3. For the BFU-E assay, cells were
described (Sudo and Karin, 2000) using anti-p38a (c-20, Santa Cruz) cultured in 3 U/ml rmEpo and 10 ng/ml rmIL-3 (R&D Systems), and
and anti-p38b (c-16, Santa Cruz) polyclonal antibodies. In addition, benzidine-positive BFU-E colonies were scored at day 8.
we used anti-p38a antibodies raised against the intact protein (Sudo
and Karin, 2000) or an N-terminal peptide (N20G, Santa Cruz). To
Flow Cytometrymeasure p38a kinase activity, cells were stimulated or not, as indi-
Single-cell suspensions of wt and mutant FLs were obtained atcated, lysed, and p38a was immunoprecipitated with anti-p38a anti-
E11.5. For analysis of reconstituted mice, peripheral blood was col-body (c-20). Immune complex kinase assays with GST-ATF2(1-99)
lected from retroorbital veins, and ammonium chloride lysis of eryth-as a substrate were performed as described (Sudo and Karin, 2000).
rocytes was performed. FL cells or peripheral blood cells (5 3 105)
were stained with monoclonal antibodies for 30 min at 48C in 75 ml
phosphate-buffered saline containing 1% bovine serum albuminReconstitution of Hematopoiesis in Lethally Irradiated Mice
FL cells from wt or p38a2/2 E112E13 embryos were used to recon- and 0.1% sodium azide. Cell suspensions were then incubated on
ice with rat anti-mouse CD16/CD32 (PharMingen) to block nonspe-stitute lethally irradiated B6.SJL (CD45.1) female mice, exposed to
950 rad of g irradiation. A total number of 1 3 106 FL cells were cific binding to Fc receptors. Subsequently, cells were incubated
with rat anti-mouse biotin-conjugated CD34 (RAM34)/streptavidin-injected into the tail vein of the host. Reconstitution of hematopoie-
sis was examined by flow cytometric analysis performed 14 weeks phycoerythrin (PE), Cy-Chrome-conjugated anti-CD44 (IM7), fluo-
rescein isothiocyanate (FITC)±conjugated anti-c-kit, anti-Ter-119later.
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(PE), anti-CD24 (HSA) (FITC, M1/69), anti-CD43 (PE, 1B11), and anti- B., Zenz, R., Wagner, E.F., and Zatloukal, K. (1999). Functions of
c-jun in liver and heart development. J. Cell Biol. 145, 1049±1061.Gr-1 (PE, RB6-8C5) (all from PharMingen). Cells were also stained
with anti-CD4 (PE, CT-CD4), Tri-Color-conjugated anti-CD8a (TC, Fahnenstich, H., Dame, C., Allera, A., and Kowalewski, S. (1996).
CT-CD8a), anti-B220 (TC, RA3-6B2), and anti-F4/80 (TC) (all from Biochemical monitoring of fetal distress with serum-immunoreactive
Caltag). Appropriate isotype control antibodies were used. Cell sur- erythropoietin. J. Perinat. Med. 24, 85±91.
face expression of the different markers was analyzed in a Becton
Foltz, I.N., Lee, J.C., Young, P.R., and Schrader, J.W. (1997). Hemo-Dickinson FACScan using CellQuest software.
poietic growth factors with the exception of interleukin-4 activate
the p38 mitogen-activated protein kinase pathway. J. Biol. Chem.Acknowledgments
272, 3296±3301.
Ghaffari, S., Smadja-Joffe, F., Oostendorp, R., Levesque, J.P., Dou-We thank J. Ihle for many useful suggestions and critical discus-
gherty, G., Eaves, A., and Eaves, C. (1999). CD44 isoforms in normalsions, K. Ikuta for advice regarding analysis of hematopoiesis, H.
and leukemic hematopoiesis. Exp. Hematol. 27, 978±993.Yoshida for advice regarding histological examination, W. McNulty
and M. Maruyama for help with genotyping and mouse breeding, Godin, I., Garcia-Porrero, J.A., Dieterlen-LieÁ vre, F., and Cumano, A.
A. Chan for help with the targeting construct, and B. Thompson for (1999). Stem cell emergence and hemopoietic activity are incompati-
manuscript assistance. We also thank M. Paulus at the UCSD Can- ble in mouse intraembryonic sites. J. Exp. Med. 190, 43±52.
cer Center mouse genetics facility (supported by the National Can-
Goldberg, M.A., Gaut, C.C., and Bunn, H.F. (1991). Erythropoietincer Institute) for help with derivation of knockout mice, and C. Plotkin
mRNA levels are governed by both the rate of gene transcriptionfor performing the real-time PCR assays. Finally, we thank J. Corbeil,
and posttranscriptional events. Blood 77, 271±277.director of the Center for AIDS Research Genomic Core at UCSD.
Greenberg, M.E. (1987). Identification of newly transcribed RNA. InK. T., T. S., and U. S. were supported by postdoctoral and visiting
Current Protocols in Molecular Biology, F.M. Ausubel, R. Brent, R.E.scholar fellowships from JSPS Research Foundation and Toyobo
Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, eds.Biotechnology Foundation, The Institute of Physical and Chemical
(New York: John Wiley & Sons), p. 4.10.Research (RIKEN), and Deutsche Forschungs Gemeinschaft (DFG),
respectively. This study was supported by grants from the National Gregory, C.J., and Eaves, A.C. (1978). Three stages of erythropoietic
Institutes of Health (ES04151, ES06376, and HL35018) and Depart- progenitor cell differentiation distinguished by a number of physical
ment of Energy (86ER60429). M. K. is the Frank and Else Schilling- and biologic properties. Blood 51, 527±537.
American Cancer Society Research Professor. A. M. D. is a recipient
Han, J., Lee, J.D., Bibbs, L., and Ulevitch, R.J. (1994). A MAP kinaseof the Erwin Schroedinger postdoctoral fellowship from the Austrian
targeted by endotoxin and hyperosmolarity in mammalian cells. Sci-Fonds zur Foerderung der Wissenschaftlichen Forscung.
ence 265, 808±811.
Heid, C.A., Stevens, J., Livak, K.J., and Williams, P.M. (1996). RealReceived December 7, 1999; revised May 24, 2000.
time quantitative PCR. Genome Res. 6, 986±994.
References Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M.,
Johnson, R., and Karin, M. (1999). Abnormal morphogenesis but
Adams, R.H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, intact IKK activation in mice lacking the IKKa subunit of the IkB
S., Valladares, A., Perez, L., Klein, R., and Nebreda, A. (2000). Essen- kinase. Science 284, 316±320.
tial role of p38alpha MAP kinase in placental but not embryonic
Ikuta, K., and Weissman, I.L. (1992). Evidence that hematopoieticcardiovascular development. Mol. Cell, in press.
stem cells express mouse c-kit but do not depend on steel factor
Allen, M., Svenesson, L., Roach, M., Hambor, J., McNeish, J., and for their generation. Proc. Natl. Acad. Sci. USA 89, 1502±1506.
Gabel, C.A. (2000). Deficiency of the stress kinase p38 results in
Ikuta, K., Kina, T., MacNeil, I., Uchida, N., Peault, B., Chien, Y.H., andembryonic lethality: characterization of the kinase dependence of
Weissman, I.L. (1990). A developmental switch in thymic lymphocytestress responses of enzyme-deficient embryonic stem cells. J. Exp.
maturation potential occurs at the level of hematopoietic stem cells.Med. 191, 859±870.
Cell 62, 863±874.
Brewster, J.L., de Valoir, T., Dwyer, N.D., Winter, E., and Gustin,
Ip, Y.T., and Davis, R.J. (1998). Signal transduction by the c-JunM.C. (1993). An osmosensing signal transduction pathway in yeast.
NH-2- terminal kinase (JNK)-from inflammation to development.Science 259, 1760±1763.
Curr. Opin. Cell Biol. 10, 205±219.Chen, C.-Y., Del Gatto-Konczak, F., Wu, Z., and Karin, M. (1998).
Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger,Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase
R.H., Gassmann, M., Gearhart, J.D., Lawler, A.M., Yu, A.Y., andpathway. Science 280, 1945±1949.
Semenza, G.L. (1998). Cellular and developmental control of O2 ho-Conrad, P.W., Rust, R.T., Han, J.H., Millhorn, D.E., and Beitner-
meostasis by hypoxia-inducible factor 1a. Genes Dev. 12, 149±162.Johnson, D. (1999). Selective activation of p38a and p38g by hyp-
oxiaÐrole in regulation of cyclin D1 by hypoxia in PC12 cells. J. Kansas, G.S., Muirhead, M.J., and Dailey, M.O. (1990). Expression of
Biol. Chem. 274, 23570±23576. the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion
molecules during normal myeloid and erythroid differentiation inCrawley, J.B., Rawlinson, L., Lali, F.V., Page, T.H., Saklatvala, J.,
humans. Blood 76, 2483±2492.and Foxwell, B.M.J. (1997). T cell proliferation in response to in-
terleukins 2 and 7 requires p38MAP kinase activation. J. Biol. Chem. Kato, T., Okazaki, K., Murakami, H., Stettler, S., Fantes, P.A., and
272, 15023±15027. Okayama, H. (1996). Stress signal, mediated by a Hog1-like map
kinase, controls sexual development in fission yeast. FEBS Lett.Dean, J.L.E., Brook, M., Clark, A.R., and Saklatvala, J. (1999). p38
378, 207±212.mitogen-activated protein kinase regulates cyclooxygenase-2
mRNA stability and transcription in lipopolysaccharide-treated hu- Kuan, C.Y., Yang, D.D., Samanta Roy, D.R., David, R.J., Rakic, P.,
man monocytes. J. Biol. Chem. 274, 264±269. and Flavell, R.A. (1999). The Jnk1 and Jnk2 protein kinases are
Degols, G., and Russell, P. (1997). Discrete roles of the Spc1 kinase required for regional specific apoptosis during early brain develop-
and the Atf1 transcription factor in the UV response of Schizosac- ment. Neuron 22, 667±676.
charomyces pombe. Mol. Cell. Biol. 17, 3356±3363. Lee, J.C., and Young, P.R. (1996). Role of Csbp/p38/Rk stress re-
Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J., and sponse kinase in Lps and cytokine signaling mechanisms. J. Leuko.
Flavell, R.A. (1998). Defective T cell differentiation in the absence Biol. 59, 152±157.
of Jnk1. Science 282, 2092±2095.
Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S.,
Ebert, B.L., and Bunn, H.F. (1999). Regulation of the erythropoietin Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter,
gene. Blood 94, 1864±1877. S.W., et al. (1994). A protein kinase involved in the regulation of
inflammatory cytokine biosynthesis. Nature 372, 739±746.Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl,
Essential Role for p38a in Erythropoiesis
231
Nagata, Y., Moriguchi, T., Nishida, E., and Todokoro, K. (1997). Acti- Zetser, A., Gredinger, E., and Bengal, E. (1999). p38 mitogen-acti-
vated protein kinase pathway promotes skeletal muscle differentia-vation of p38 MAP kinase pathway by erythropoietin and
interleukin-3. Blood 90, 929±934. tionÐparticipation of the MEF2C transcription factor. J. Biol. Chem.
274, 5193±5200.Neubauer, H., Cumano, A., Muller, M., Wu, H., Huffstadt, U., and
Pfeffer, K. (1998). Jak2 deficiency defines an essential develop-
mental checkpoint in definitive hematopoiesis. Cell 93, 397±409.
New, L., and Han, J. (1998). The p38 MAP kinase pathway and its
biological function. Trends Cardiovasc. Med. 8, 220±229.
PageÁ s, G., GueÂ in, S., Grall, D., Bonino, F., Smith, A., Anjuere, F.,
Auberger, P., and PouysseÂ gur, J. (1999). Defective thymocyte matu-
ration in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374±
1377.
Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.C.,
Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., vanDeursen,
J.M., et al. (1998). Jak2 is essential for signaling through a variety
of cytokine receptors. Cell 93, 385±395.
Puri, P.L., Wu, Z., Zhang, P., Wood, L.D., Bhakta, K.S., Han, J.,
Feramisco, J.R., Karin, M., and Wang, J.Y.J. (2000). Induction of
terminal differentiation by constitutive activation of p38 MAP-kinase
in human rhabdomyosarcoma cells. Genes Dev. 14, 574±584.
Richard, D.E., Berra, E., Gothie, E., Roux, D., and Pouyssegur, J.
(1999). p42/p44 mitogen-activated protein kinases phosphorylate
hypoxia-inducible factor 1 alpha (HIF-1 alpha) and enhance the tran-
scriptional activity of HIF-1. J. Biol. Chem. 274, 32631±32637.
Ryan, H.E., Lo, J., and Johnson, R.S. (1998). HIF-1a is required for
solid tumor formation and embryonic vascularization. EMBO J. 17,
3005±3015.
Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J.-P., Jo-
chum, W., Wagner, E.F., and Karin, M. (1999a). JNK2 is required for
efficient T-cell activation and apoptosis but not for normal lympho-
cyte development. Curr. Biol. 9, 116±125.
Sabapathy, K., Jochum, W., Hochedlinger, K., Chang, L., Karin, M.,
and Wagner, E.F. (1999b). Defective neural tube morphogenesis and
altered apoptosis in the absence of both JNK1 and JNK2. Mech.
Dev. 89, 115±124.
Shiozaki, K., and Russell, P. (1996). Conjugation, meiosis, and the
osmotic stress response are regulated by Spc1 kinase through Atf1
transcription factor in fission yeast. Genes Dev. 10, 2276±2288.
Su, B., and Karin, M. (1996). Mitogen-activated protein kinase cas-
cades and regulation of gene expression. Curr. Opin. Immunol. 8,
402±411.
Sudo, T., and Karin, M. (2000). Assays for JNK and p38 MAP kinase.
Meth. Enzymol., in press.
Waskiewicz, A.J., and Cooper, J.A. (1995). Mitogen and stress re-
sponse pathways - map kinase cascades and phosphatase regula-
tion in mammals and yeast. Curr. Opin. Cell Biol. 7, 798±805.
Weiss, M.J., Keller, G., and Orkin, S.H. (1994). Novel insights into
erythroid development revealed through in vitro differentiation of
GATA-1 embryonic stem cells. Genes Dev. 8, 1184±1197.
Whitelaw, E., Tsai, S.F., Hogben, P., and Orkin, S.H. (1990). Regu-
lated expression of globin chains and the erythroid transcription
factor Gata-1 during erythropoiesis in the developing mouse. Mol.
Cell. Biol. 10, 6596±6606.
Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C.-Y.A., Shyu,
A.-B., Muller, M., Gaestel, M., Resch, K., and Holtmann, H. (1999).
The p38 MAP kinase pathway signals for cytokine-induced mRNA
stabilization via MAP kinase-activated protein kinase 2 and an AU-
rich region-targeted mechanism. EMBO J. 18, 4969±4980.
Wu, H., Liu, X., Jaenisch, R., and Lodish, H.F. (1995). Generation of
committed erythroid Bfu-E and Cfu-E progenitors does not require
erythropoietin or the erythropoietin receptor. Cell 83, 59±67.
Wu, Z., Woodring, P.J., Bhakta, K.S., Tamura, K., Wen, F., Feramisco,
J.R., Karin, M., Wang, J.Y.J., and Puri, P.L. (2000). p38 and ERK
MAP kinases regulate the myogenic program at multiple steps. Mol.
Cell. Biol. 20, 3951±3964.
Yang, D., Kuan, C.-Y., Whitmarsh, A.J., Rincon, M., Zheng, T.S.,
Davis, R.J., Rakic, P., and Flavell, R.A. (1997). Absence of excitotoxi-
city-induced apoptosis in the hippocampus of mice lacking the Jnk3
gene. Nature 389, 865±870.
